Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders

Yildiz A., Guryildirim M., Pepeler M. S., Yazol M., ÖZHAN OKTAR S., Acar K.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.24, sa.7, ss.1102-1108, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 7
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1177/1076029618766260
  • Dergi Adı: CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1102-1108
  • Anahtar Kelimeler: flow-mediated dilatation, endothelial dysfunction, myeloproliferative disorders, risk factors, thrombosis, POLYCYTHEMIA-VERA PATIENTS, LOW-DOSE ASPIRIN, ESSENTIAL THROMBOCYTHEMIA, RISK-FACTORS, ACUTE-LEUKEMIA, CD40 LIGAND, THROMBOSIS, NEOPLASMS, COMPLICATIONS, LEUKOCYTOSIS
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Thrombosis is the most important cardiovascular complication of classical myeloproliferative disorders (MPDs). Endothelial dysfunction (ED) is known to play a major role in the mechanism of thrombophilia in MPDs.